Durham, North Carolina-based Ramona Optics, which develops imaging systems for biopharma and biomedical use, has closed an oversubscribed $25 million Series ...
Which Drugs and Pharma Shaped Oncology in the First Half of 2026? Breaking Down FDA Approvals / BIGR, FDA, OncoDaily, ...
Frontier Medicines Corporation has expanded its leadership team with the appointments of Aaron Weitzman, M.D., as Chief Medical Officer, Mike... Read More ...
In 2025, global healthcare private equity hit a record $191 billion in deal value, surpassing the 2021 peak, according to ...
Barchart on MSN
As Claude enters the gene-editing arena, there’s still a long-term case for BEAM stock
Some of biology's biggest breakthroughs began with a scientist noticing something odd. An enzyme found in a Yellowstone hot ...
Join IBN’s Carmel Fisher for a fresh conversation with Anthony Durkacz, Co-Founder and Executive Co-Chair of Quantum BioPharma, as he provides an update on the company’s Lucid-MS Phase 2 program, the ...
There’s no denying that there has been an explosion in the use of drug delivery devices. Part of the growing trend is coming ...
The last few years have been pretty brutal for cultivated meat, but can a leaner, meaner, pet food-focused approach prevail?
AI-designed gene therapy company Basecamp Research closed a $140 million Series C to train EDEN biological AI models on ...
Ramona Optics, Inc. (“Ramona”), a leading biotools company advancing human health with massively parallel computational imaging that delivers unrivaled precision and scale to biopharma and biomedical ...
The London Summit will bring together more than 2,000 global leaders under the theme 'Technology + Human Purpose' to explore the next era of AI ...
On September 28, SBP Group (01177.HK) announced that its core subsidiary, (CTTQ), has entered into a strategic biosimilars partnership with STADA Arzneimittel AG (STADA), a leading European healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results